These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6134944)

  • 21. Direct diagnosis of carriers of point mutations in Duchenne muscular dystrophy.
    Yau SC; Roberts RG; Bobrow M; Mathew CG
    Lancet; 1993 Jan; 341(8840):273-5. PubMed ID: 8093919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting the Duchenne carrier by ultrasound and computerized tomography.
    Heckmatt JZ; Dubowitz V
    Lancet; 1983 Dec; 2(8363):1364. PubMed ID: 6139695
    [No Abstract]   [Full Text] [Related]  

  • 23. Myoglobin RIA in detecting carriers of Duchenne's muscular dystrophy.
    Sabria-Leal M; Gimeno-Leal JM; Paret-Masana A; Rey-Joly Barroso C
    Eur Neurol; 1986; 25(4):253-5. PubMed ID: 3720800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier detection and prenatal diagnosis in X linked muscular dystrophy using restriction fragment length polymorphisms.
    Lindlöf M; Kääriäinen H; Davies KE; de la Chapelle A
    J Med Genet; 1986 Dec; 23(6):560-72. PubMed ID: 2879928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carrier detection in Duchenne muscular dystrophy.
    Nicholson GA; Gardner-Medwin D; Walton JN
    Lancet; 1979 Aug; 2(8138):367. PubMed ID: 89433
    [No Abstract]   [Full Text] [Related]  

  • 26. Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA.
    Roberts RG; Bentley DR; Barby TF; Manners E; Bobrow M
    Lancet; 1990 Dec 22-29; 336(8730):1523-6. PubMed ID: 1979364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carrier detection in Duchenne muscular dystrophy.
    Young A; Stokes M
    Lancet; 1982 Oct; 2(8305):994. PubMed ID: 6127496
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of Duchenne muscular dystrophy carrier status by single strand conformation polymorphism analysis of deleted regions of the dystrophin locus.
    Richards RI; Friend K
    J Med Genet; 1991 Dec; 28(12):856-9. PubMed ID: 1757962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure.
    Bakker E; Bonten EJ; De Lange LF; Veenema H; Majoor-Krakauer D; Hofker MH; Van Ommen GJ; Pearson PL
    J Med Genet; 1986 Dec; 23(6):573-80. PubMed ID: 2879929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of carriers of Duchenne/Becker muscular dystrophy by a novel method based on detection of junction fragments in the dystrophin gene.
    Yamagishi H; Kato S; Hiraishi Y; Ishihara T; Hata J; Matsuo N; Takano T
    J Med Genet; 1996 Dec; 33(12):1027-31. PubMed ID: 9004137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carrier detection in Duchenne muscular dystrophy.
    Bundey S; Edwards JH; Insley J
    Lancet; 1979 Apr; 1(8121):881. PubMed ID: 86132
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of adrenoleucodystrophy carriers by means of evoked potentials.
    Moloney JB; Masterson JG
    Lancet; 1982 Oct; 2(8303):852-3. PubMed ID: 6126714
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis.
    Ioannou P; Christopoulos G; Panayides K; Kleanthous M; Middleton L
    Neurology; 1992 Sep; 42(9):1783-90. PubMed ID: 1513470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier detection in Duchenne muscular dystrophy.
    Carter CO
    Lancet; 1979 May; 1(8123):979. PubMed ID: 87648
    [No Abstract]   [Full Text] [Related]  

  • 36. Carrier-detection rate and age in Duchenne muscular dystrophy.
    Thomson WH; Smith I; Elton RA
    Lancet; 1979 Apr; 1(8120):829. PubMed ID: 86076
    [No Abstract]   [Full Text] [Related]  

  • 37. Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis.
    Emery AE
    Br Med Bull; 1980 May; 36(2):117-22. PubMed ID: 7020836
    [No Abstract]   [Full Text] [Related]  

  • 38. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myotonic dystrophy- early detection and genetic counselling by T. Schubert et al.
    Bundey S
    J Neurol; 1982; 226(4):295. PubMed ID: 6174712
    [No Abstract]   [Full Text] [Related]  

  • 40. A register based system for gene tracking in Duchenne muscular dystrophy.
    Read AP; Kerzin-Storrar L; Mountford RC; Elles RG; Harris R
    J Med Genet; 1986 Dec; 23(6):581-6. PubMed ID: 2879930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.